BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 8977758)

  • 1. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M; Shackleton CH; Mantero F; Stewart PM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M; Delitala G; Mantero F; Stewart PM; Shackleton CH
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
    Stiefel P; García-Morillo JS; Jimenez L; Pamies E; Miranda ML; Carneado J; Villar J; Leal-Cerro A
    Endocrine; 2002 Aug; 18(3):279-84. PubMed ID: 12450320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
    Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
    Kerstens MN; Buter H; Navis GJ; Dullaart RP
    Eur J Clin Invest; 2002 Jul; 32(7):513-8. PubMed ID: 12153552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K; Remer T; Fritsche A; Häring HU; Maser-Gluth C
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
    Hoshiro M; Ohno Y; Masaki H; Iwase H; Aoki N
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
    Ferrari P; Sansonnens A; Dick B; Frey FJ
    Hypertension; 2001 Dec; 38(6):1330-6. PubMed ID: 11751713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids.
    Główka FK; Kosicka K; Karaźniewicz-Łada M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):283-9. PubMed ID: 20018571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN; Riemens SC; Sluiter WJ; Pratt JJ; Wolthers BG; Dullaart RP
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):403-11. PubMed ID: 10762282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A; Takasaka T; Shibasaki H; Kasuya Y; Kawashima S; Yamada A; Furuta T
    Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activity in healthy men.
    Kerstens MN; van der Kleij FG; Boonstra AH; Sluiter WJ; van der Molen JC; Navis G; Dullaart RP
    Kidney Int; 2004 Jun; 65(6):2065-70. PubMed ID: 15149319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
    J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR; Andrew R; MacLeod KM; Padfield PL
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice.
    Ceccato F; Antonelli G; Barbot M; Zilio M; Mazzai L; Gatti R; Zaninotto M; Mantero F; Boscaro M; Plebani M; Scaroni C
    Eur J Endocrinol; 2014 Jul; 171(1):1-7. PubMed ID: 24743401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of activity of 11β-hydroxysteroid dehydrogenase type 2 on serum potassium levels in Cushing's syndrome patients].
    Lian P; Li H; Zhang Y; Ji Z
    Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):929-32. PubMed ID: 26081057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decreased activity of 11-beta-hydroxysteroid dehydrogenase in patients with Cushing's syndrome].
    Stiefel P; Jiménez L; García-Morillo JS; Leal A; Villar J; Carneado J
    Med Clin (Barc); 2000 Jun; 115(3):90-2. PubMed ID: 10965482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.